(3S,4R,5S)-3-ACETOXY-5-[[1S,(3E)]-1-(TERT.-BUTYLDIPHENYLSILYLOXY)-4-PHENYL-BUT-3-ENYL]-4-(TOSYLAMINO)-TETRAHYDROFURAN-2-ONE
Compound with spectra: 1 NMR
![(3S,4R,5S)-3-ACETOXY-5-[[1S,(3E)]-1-(TERT.-BUTYLDIPHENYLSILYLOXY)-4-PHENYL-BUT-3-ENYL]-4-(TOSYLAMINO)-TETRAHYDROFURAN-2-ONE](/api/compound/9U1VZsaYHLd.png?ph=true&h=300&w=458 "(3S,4R,5S)-3-ACETOXY-5-[[1S,(3E)]-1-(TERT.-BUTYLDIPHENYLSILYLOXY)-4-PHENYL-BUT-3-ENYL]-4-(TOSYLAMINO)-TETRAHYDROFURAN-2-ONE")
| SpectraBase Compound ID | 9U1VZsaYHLd |
|---|---|
| InChI | InChI=1S/C39H43NO7SSi/c1-28-24-26-31(27-25-28)48(43,44)40-35-36(46-38(42)37(35)45-29(2)41)34(23-15-18-30-16-9-6-10-17-30)47-49(39(3,4)5,32-19-11-7-12-20-32)33-21-13-8-14-22-33/h6-22,24-27,34-37,40H,23H2,1-5H3/b18-15+/t34-,35+,36+,37-/m0/s1 |
| InChIKey | FNHGVECCJIGQFM-SDFBXMPPSA-N |
| Mol Weight | 697.9 g/mol |
| Molecular Formula | C39H43NO7SSi |
| Exact Mass | 697.25295 g/mol |
| Enantiomer InChIKey | FNHGVECCJIGQFM-KTVYUNCZSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(3S,4R,5S)-3-ACETOXY-4-[(ACETYL)-(TOSYL)-AMINO]-5-[(TERT.-BUTYLDIPHENYLSILYLOXY)-METHYL]-TETRAHYDROFURAN-2-ONE
(6R,8R)-8-((2S,3R,4S,5R)-5-(2-(Benzyloxy)ethyl)-4-methyl-3-(phenylselanyl) tetrahydrofuran-2-yl)-2,2,11,11-tetramethyl-3,3,10,10-tetraphenyl-4,9-dioxa-3,10-disiladodecan-6-yl isobutyrate
5-Octenoic acid, 8-[6-[1-(acetyloxy)-2-nitro-3-(2-pentyl-1,3-dioxolan-2-yl)propyl]-2,2 -dimethyl-1,3-dioxan-4-yl]-8-[[(1,1-dimethylethyl)diphenylsilyl]oxy]- , methyl ester
METHYL-2,3,4,6-TETRA-O-ACETYL-ALPHA-D-MANNOPYRANOSYL-(1->4)-6-O-(TERT.-BUTYLDIPHENYLSILYL)-2,3-DI-O-METHYL-ALPHA-D-GLUCOPYRANOSIDE
#8;METHYL-2,3,4,6-TETRA-O-METHYL-ALPHA-D-MANNOPYRANOSYL-(1->4A)-6-O-(TERT.-BUTYLDIPHENYLSILYL)-2,3-DI-O-METHYL-4A-HYDROXY-4A-CARBA-ALPHA-D-GLUCOPYRANOSIDE
3,5-DI-O-(TERT.-BUTYLDIPHENYLSILYL)-4-C-(HYDROXYMETHYL)-1,2-O-ISOPROPYLIDENE-ALPHA-D-XYLOFURANOSIDE
(8R,8aS)-7-[[(Dimethylethyl)dimethylsilyl]oxy]-8-Hydroxy-8-methyl-6-((Z)-2(R,5-dimethyl-7-[[(dimethylethyl)diphenylsilyl]oxy]-6-oxo-4-octen-1-ylidene)octahydroindolozine
(1S,2S,3S,4S,5S)-2-ACETOXY-1-AZIDO-3-(TERT.-BUTYLDIPHENYLSILYLOXY)-4,5-DIHYDROXYCYCLOHEX-5-YL-METHYL-ACETATE
N-(1,3,4,6,7-Penta-O-acetyl-2-deoxy-A-D-gly-L-glu-hepto-py-2-yl)-N'- (1,3,4,6-tet-O-ac-2-deoxy-B-D-glucopy-2-yl)-thiourea
D-Glucopyranosylamine, O-2,3,4,6-tetra-O-acetyl-.beta.-D-glucopyranosyl-(1.fwdarw.3)-O-2,4,6-tri-O-acetyl-.beta.-D-glucopyranosyl-(1.fwdarw.3)-N-(4-methylphenyl)-, 2,4,6-triacetate
| Title | Journal or Book | Year |
|---|---|---|
| Enantiospecific Synthesis of a Protected Equivalent of APTO, the β-Amino Acid Fragment of Microsclerodermins C and D, by Aziridino-γ-lactone Methodology | European Journal of Organic Chemistry | 2009 |